CPPopt Guided Therapy: Assessment of Target Effectiveness

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

February 27, 2020

Study Completion Date

February 27, 2020

Conditions
Brain Injuries, TraumaticCerebrovascular CirculationHomeostasis
Interventions
OTHER

For both groups, CPP targets will be achieved first by ICP control if this is raised and then by ABP support by titration (up or down) of vasopressors and fluids according to local protocols.

For both groups, CPP targets will be achieved first by ICP control if this is raised and then by ABP support by titration (up or down) of vasopressors and fluids according to local protocols.

Trial Locations (2)

Unknown

Academic Hospital Leuven, Leuven

The Addenbrooke's Hospital, Cambridge

All Listed Sponsors
collaborator

European Society of Intensive Care Medicine

OTHER

lead

Maastricht University Medical Center

OTHER

NCT02982122 - CPPopt Guided Therapy: Assessment of Target Effectiveness | Biotech Hunter | Biotech Hunter